NDC 64725-1834

Novolin N

Human Insulin

Novolin N is a Subcutaneous Injection, Suspension in the Human Otc Drug category. It is labeled and distributed by Tya Pharmaceuticals. The primary component is Insulin Human.

• Product ID: 64725-1834_88240c8b-10c5-43b4-8a36-020380cea930
• NDC: 64725-1834
• Product Type: Human Otc Drug
• Proprietary Name: Novolin N
• Generic Name: Human Insulin
• Dosage Form: Injection, Suspension
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 1991-07-01
• Marketing Category: NDA / NDA
• Application Number: NDA019959
• Labeler Name: TYA Pharmaceuticals
• Substance Name: INSULIN HUMAN
• Active Ingredient Strength: 100 [iU]/mL
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 64725-1834-1

10 mL in 1 VIAL (64725-1834-1)

• Marketing Start Date: 1991-07-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 64725-1834-1 [64725183401]

Novolin N INJECTION, SUSPENSION

• Marketing Category: NDA
• Application Number: NDA019959
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 1991-07-01
• Inactivation Date: 2019-11-27

Drug Details

Active Ingredients

Ingredient	Strength
INSULIN HUMAN	100 [iU]/mL

OpenFDA Data

• SPL SET ID: 99c995f1-522e-42aa-b45a-117e0af77d81
• Manufacturer:
  • TYA Pharmaceuticals
• UNII:
  • 1Y17CTI5SR
• RxNorm Concept Unique ID - RxCUI:
  • 311027
  • 311028

NDC Crossover Matching brand name "Novolin N" or generic name "Human Insulin"

NDC	Brand Name	Generic Name
0169-1833	Novolin	Human Insulin
0169-1834	Novolin	Human Insulin
0169-1837	Novolin	Human Insulin
0169-3003	Novolin	Human Insulin
0169-3004	Novolin	Human Insulin
0169-3007	Novolin	Human Insulin
50090-0403	Novolin	Human Insulin
50090-0497	Novolin	Human Insulin
50090-0498	Novolin	Human Insulin
64725-1833	Novolin	Human Insulin
64725-1834	Novolin	Human Insulin
64725-1837	Novolin	Human Insulin
68071-1701	Novolin	Human Insulin